Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Similarity of Biocon Insulin N and Humulin N in Healthy Volunteers
NCT04022304Phase 1Completed
- Sponsor
- Biocon
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of human insulin in diabetes mellitus (DM) (6 arms), sponsored by Biocon. Primary endpoints: Area under the insulin concentration curve from 0 to 24 hours, Maximum observed insulin concentration and 2 more. Started Jun 2019; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT04022304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022304.